- edoc-Server Home
- Browsing by Author
Browsing by Author "Bartmeyer, Barbara"
Now showing items 1-20 of 23
-
2011-09-09ZeitschriftenartikelCalculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort. Stoll, Matthias; Kollan, Christian; Bergmann, Frank; Bogner, Johannes; Faetkenheuer, Gerd; Fritzsche, Carlos; Hoeper, Kirsten; Horst, Heinz-August; Lunzen, Jan van; Plettenberg, Andreas; Reuter, Stefan; Rockstroh, Jürgen; Stellbrink, Hans-Jürgen; Hamouda, Osamah; Bartmeyer, BarbaraBackground/Aim of the Study: The study aimed to determine the cost impacts of antiretroviral drugs by analysing a longterm follow-up of direct costs for combined antiretroviral therapy, cART,-regimens in the nationwide ...
-
2008-07-23ZeitschriftenartikelCCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual Oh, Djin-Ye; Jessen, Heiko; Kücherer, Claudia; Neumann, Konrad; Oh, Nari; Poggensee, Gabriele; Bartmeyer, Barbara; Jessen, Arne; Pruss, Axel; Schumann, Ralf R.; Hamouda, OsamahBackground: Homozygosity (Δ32/Δ32) for the 32 bp deletion in the chemokine receptor 5 (CCR5) gene is associated with strong resistance against HIV infection. Heterozygosity is associated with protection of HIV-1 disease ...
-
2014-11-02ZeitschriftenartikelCharacterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany Meixenberger, Karolin; Yousef, Kaveh Pouran; Somogyi, Sybille; Fiedler, Stefan; Bartmeyer, Barbara; Kleist, Max von; Kücherer, Claudia
-
2013-11-24ZeitschriftenartikelEpidemiologische Entwicklung bei ausgewählten sexuell übertragbaren Infektionen (STI) in Deutschland Hamouda, Osamah; Bremer, Viviane; Marcus, Ulrich; Bartmeyer, BarbaraDie Zahl der Menschen, die mit einer HIV-Infektion leben, nimmt seit Mitte der 1990er-Jahre zu und wird voraussichtlich in den nächsten Jahren weiter ansteigen. Die HIV-Epidemie in Deutschland wird nach wie vor am stärksten ...
-
2014-08-22ZeitschriftenartikelEstimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany Schmidt, Daniel; Kollan, Christian; Fätkenheuer, Gerd; Schülter, Eugen; Stellbrink, Hans-Jürgen; Noah, Christian; Jensen, Björn-Erik Ole; Stoll, Matthias; Bogner, Johannes R.; Eberle, Josef; Meixenberger, Karolin; Kücherer, Claudia; Hamouda, Osamah; Bartmeyer, BarbaraObjective: We assessed trends in the proportion of transmitted (TDR) and acquired (ADR) HIV drug resistance and associated mutations between 2001 and 2011 in the German ClinSurv-HIV Drug Resistance Study. Method: ...
-
2021-01-22ZeitschriftenartikelEverything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018) Schmidt, Daniel; Kollan, Christian; Stoll, Matthias; Hamouda, Osamah; Bremer, Viviane; Kurth, Tobias; Bartmeyer, BarbaraBackground The aim of this study was to develop a standardized method to reconstruct persons’ individual viral load (VL) courses to determine viral suppression and duration of viremia for the HIV care continuum in Germany ...
-
2014-05-01ZeitschriftenartikelFirst Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study Knyphausen, Fabia zu; Scheufele, Ramona; Kücherer, Claudia; Jansen, Klaus; Somogyi, Sybille; Dupke, Stephan; Jessen, Heiko; Schürmann, Dirk; Hamouda, Osamah; Meixenberger, Karolin; Bartmeyer, BarbaraBackground: Transmission of drug-resistant HIV-1 (TDR) can impair the virologic response to antiretroviral combination therapy. Aim of the study was to assess the impact of TDR on treatment success of resistance test-guided ...
-
2015-03-17ZeitschriftenartikelFrom pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany Schmidt, Daniel; Kollan, Christian; Stoll, Matthias; Stellbrink, Hans-Jürgen; Plettenberg, Andreas; Fätkenheuer, Gerd; Bergmann, Frank; Bogner, Johannes R.; Lunzen, Jan van; Rockstroh, Jürgen; Esser, Stefan; Jensen, Björn-Erik Ole; Horst, Heinz-August; Fritzsche, Carlos; Kühne, Andrea; Heiden, Matthias an der; Hamouda, Osamah; Bartmeyer, BarbaraBackground: This study aimed to determine the number of people living with HIV receiving antiretroviral therapy (ART) between 2006 and 2013 in Germany by using the available numbers of antiretroviral drug prescriptions ...
-
2015-08-31ZeitschriftenartikelHIV Testing and Diagnosis Rates in Kiev, Ukraine: April 2013 - March 2014 Kücherer, Claudia; Simmons, Ruth; Bartmeyer, Barbara; Malyuta, Ruslan; Chentsova, Nelli; Medoeva, Antonia; Kruglov, Yuri; Yurchenko, Alexander; Copas, Andrew; Porter, Kholoud; Hamouda, OsamahObjective: Data from Ukraine on risk factors for HIV acquisition are limited. We describe the characteristics of individuals testing for HIV in the main testing centres of the Ukrainian capital Kiev, including HIV risk ...
-
2014-06-03ZeitschriftenartikelImproved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort Hauser, Andrea; Santos-Hövener, Claudia; Meixenberger, Karolin; Zimmermann, Ruth; Somogyi, Sybille; Fiedler, Stefan; Hofmann, Alexandra; Bartmeyer, Barbara; Jansen, Klaus; Hamouda, Osamah; Bannert, Norbert; Kücherer, ClaudiaBackground: The variety and limitations of current laboratory methods for estimating HIV-incidence has driven attempts to improve and standardize the performance of serological ‘Tests for Recent HIV-Infections’ (TRI). ...
-
2018-11-08ZeitschriftenartikelIncreasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses Hauser, Andrea; Hofmann, Alexandra; Meixenberger, Karolin; Altmann, Britta; Hanke, Kirsten; Bremer, Viviane; Bartmeyer, Barbara; Bannert, NorbertBackground Molecular surveillance of newly diagnosed HIV-infections is important for tracking trends in circulating HIV-variants, including those with transmitted drug resistances (TDR) to sustain ART efficacy. Methods Dried ...
-
2017-11-14ZeitschriftenartikelMolecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors Meixenberger, Karolin; Yousef, Kaveh Pouran; Smith, Maureen Rebecca; Somogyi, Sybille; Fiedler, Stefan; Bartmeyer, Barbara; Hamouda, Osamah; Bannert, Norbert; Kleist, Max von; Kücherer, ClaudiaBackground: Detailed knowledge of the evolutionary potential of polymorphic sites in a viral protein is important for understanding the development of drug resistance in the presence of an inhibitor. We therefore set ...
-
2017-01-12ZeitschriftenartikelNational molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014 Hauser, Andrea; Hofmann, Alexandra; Hanke, Kirsten; Bremer, Viviane; Bartmeyer, Barbara; Kücherer, Claudia; Bannert, NorbertTo enable an up-to-date molecular analysis of human immunodeficiency virus (HIV) genotypes circulating in Germany we have established a surveillance system based on recently acquired HIV infections. New HIV infections are ...
-
2019-05-09ZeitschriftenartikelPiloting a surveillance system for HIV drug resistance in the European Union van de Laar, Marita J. W.; Bosman, Arnold; Pharris, Anastasia; Andersson, Emmi; Assoumou, Lambert; Ay, Eva; Bannert, Norbert; Bartmeyer, Barbara; Brady, Melissa; Chaix, Marie-Laure; Descamps, Diane; Dauwe, Kenny; Fonager, Jannik; Hauser, Andrea; Lunar, Maja; Mezei, Martha; Poljak, Mario; van Sighem, Ard; Verhofstede, Chris; Amato-Gauci, Andrew; Broberg, Eeva K.Background A steady increase in HIV drug resistance (HIVDR) has been demonstrated globally in individuals initiating first-line antiretroviral therapy (ART). To support effective use of ART and prevent spread of HIVDR, ...
-
2021-11-04ZeitschriftenartikelPrEP-Evaluation EvE-PrEP – Ergebnisse einer Befragung zum PrEP-Versorgungsgeschehen in HIV-Schwerpunktzentren des dagnä-Netzwerks Robert Koch-Institut; Schmidt, Daniel; Schikowski, Tim; Friebe, Martin; Kollan, Christian; Bartmeyer, Barbara; Bremer, Viviane; Hanhoff, Nikola; Rüsenberg, Robin; Schewe, KnudSeit September 2019 ist die Präexpositionsprophylaxe (PrEP) bei HIV-Infektion Teil des Leistungskatalo-ges der gesetzlichen Krankenversicherung (GKV). Mit der Einführung wurde auch eine Evaluation der neuen Leistung ...
-
2024-04-28ZeitschriftenartikelPrEP-Surveillance in Deutschland – Ergebnisse der dritten halbjährlichen Befragung in HIV-Schwerpunkteinrichtungen Schmidt, Daniel; Zeynip, Ates; Friebe, Martin; Kollan, Christian; Bremer, Viviane; Bartmeyer, Barbara; Hanoff, Nikola; Schewe, KnudIm Rahmen des vom Bundesministerium für Gesundheit geförderten Projekts „Surveillance der Versorgung mit der HIV-Präexpositionsprophylaxe innerhalb der GKV in Deutschland“ (PrEP-Surv) werden halbjährliche Befragungen zu ...
-
2010-10-07ZeitschriftenartikelPrevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort Bartmeyer, Barbara; Kücherer, Claudia; Houareau, Claudia; Werning, Johanna; Keeren, Katrin; Somogyi, Sybille; Kollan, Christian; Jessen, Heiko; Dupke, Stephan; Hamouda, OsamahBackground: The aim of this study is to analyse the prevalence of transmitted drug resistance, TDR, and the impact of TDR on treatment success in the German HIV-1 Seroconverter Cohort. Methods: Genotypic resistance ...
-
2022-01-27ZeitschriftenartikelRisk of Guillain–Barré syndrome after vaccination against human papillomavirus: a systematic review and meta-analysis, 1 January 2000 to 4 April 2020 Boender, T. Sonia; Bartmeyer, Barbara; Coole, Louise; Wichmann, Ole; Harder, ThomasBackground: Guillain–Barré syndrome (GBS) is a rare autoimmune disease that can follow viral infections and has in a few cases been linked to vaccinations. Pre-licensure clinical trials did not observe an association ...
-
2023-02-16ZeitschriftenartikelSurveillance der Versorgung mit der HIV-Präexpositionsprophylaxe in Deutschland Schmidt, Daniel; Schikowski, Tim; Friebe, Martin; Kollan, Christian; Bremer, Viviane; Bartmeyer, Barbara; Hanhoff, Nikola; Rüsenberg, Robin; Schewe, KnudGesetzlich Krankenversicherte mit einem substanziellen HIV-Infektionsrisiko haben seit September 2019 Anspruch auf die HIV-Präexpositionsprophylaxe (PrEP). Basierend auf den Evaluationsergebnissen zur Einführung der PrEP ...
-
2023-07-20ZeitschriftenartikelSurveillance der Versorgung mit der HIV-Präexpositionsprophylaxe in Deutschland Schmidt, Daniel; Ates, Zeynep; Friebe, Martin; Kollan, Christian; Bremer, Viviane; Bartmeyer, Barbara; Hanhoff, Nikola; Schewe, KnudIm Rahmen des vom Bundesministerium für Gesundheit geförderten Projekts „Surveillance der Versorgung mit der HIV-Präexpositionsprophylaxe innerhalb der GKV in Deutschland“ (PrEP-Surv) werden halbjährliche Befragungen zu ...